José Miguel Pardo Sánchez

Dr. José Miguel Pardo Sánchez

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2021 in Cancers
Verified
Journal Article
Open access
PDF file
JSJosé Miguel Pardo Sánchez
José Miguel Pardo Sánchez
NMNuria Mancheño
Nuria Mancheño
JCJosé Cerón
José Cerón
CJCarlos Jordá
Carlos Jordá
EAEmilio Ansotegui
Emilio Ansotegui
RFRosa Farràs
Rosa Farràs
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer death worldwide. The high mortality is very often a consequence of its late diagnosis when the cancer is already locally advanced or has disseminated. Advances in the study of NSCLC tumors have been achieved by using in vivo models, such as patient-derived xenografts. Apart from drug screening, this approach may also be useful for study of the biology of the tumors. In the present study, surgically resected primary lung cancer samples (n = 33) were implanted in immunodeficient mice, and nine were engrafted successfully, including seven adenocarcinomas, one squamous-cell carcinoma, and one large-cell carcinoma. ADC tumors bearing the KRAS-G12C mutation were the most frequently engrafted in our PDX collection. Protein expression of vimentin, ezrin, and Ki67 were evaluated in NSCLC primary tumors and during serial transplantation by immunohistochemistry, using H-score. Our data indicated a more suitable environment for solid adenocarcinoma, compared to other lung tumor subtypes, to grow and preserve its architecture in mice, and a correlation between higher vimentin and ezrin expression in solid adenocarcinomas. A correlation between high vimentin expression and lung adenocarcinoma tumors bearing KRAS-G12C mutation was also observed. In addition, tumor evolution towards more proliferative and mesenchymal phenotypes was already observed in early PDX tumor passages. These PDX models provide a valuable platform for biomarker discovery and drug screening against tumor growth and EMT for lung cancer translational research.

27 September 2021 in Cancers
Verified
Journal Article
Open access
PDF file
JSJosé Miguel Pardo Sánchez
José Miguel Pardo Sánchez
NMNuria Mancheño
Nuria Mancheño
JCJosé Cerón
José Cerón
CJCarlos Jordá
Carlos Jordá
EAEmilio Ansotegui
Emilio Ansotegui
RFRosa Farràs
Rosa Farràs
The authors would like to make a correction to their published paper

29 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
UHUnai Heras
Unai Heras
JSJosé Miguel Pardo Sánchez
José Miguel Pardo Sánchez
JBJone Berasain
Jone Berasain
ITIune Toledo
Iune Toledo
LILeire Iturriaga
Leire Iturriaga
ACAmaia Cipitria
Amaia Cipitria
Breast cancer metastasis can emerge after disease-free periods through the reawakening of dormant disseminated cancer cells. Despite evidence that the extracellular matrix (ECM) modulates this phenomenon, biophysical cues regulating dormancy fate and therapeutic responses remain poorly understood. Here, we engineered stiffness-matched gelatin methacryloyl (GelMA) and alginate-based 3D matrices to disentangle matrix stiffness from adhesion and degradability and uncover their contributions to dormancy. Deep learning-based 3D segmentation revealed that adhesive and degradable matrices supported rounded and proliferative tumour masses, whereas inert matrices favoured single cell dormancy. Within inert matrices, stiffness further determined dormancy fate, with soft matrices activating SOX9-associated transient stem-like dormancy, while stiff matrices reduced cell volume, increased intracellular macromolecular crowding of proteins and induced NR2F1-associated prolonged dormancy marked by autophagy and cellular stress. Transiently dormant cells retrieved from soft matrices retained dormancy memory and failed to form tumours in chicken chorioallantoic membranes, demonstrating persistence of matrix-induced states after removal of biophysical cues. Moreover, patient-derived cells in soft inert matrices recapitulated transient dormant states and exhibited therapy resistance. We demonstrate that tuneable biophysical cues shape distinct dormancy states, linking matrix mechanics to dormancy regulation and therapeutic response.

8 January 2026 in bioRxiv
Verified
Preprint
Open access
LFLaura Fallert
Laura Fallert
AUAne Urigoitia-Asua
Ane Urigoitia-Asua
JSJosé Miguel Pardo Sánchez
José Miguel Pardo Sánchez
EAElena Arizaga-Batiz
Elena Arizaga-Batiz
RZRosa M. Zubizarreta-Susperregui
Rosa M. Zubizarreta-Susperregui
ACAmaia Cipitria
Amaia Cipitria
Metastatic breast cancer (BC) is the main cause of cancer-related death in women. Accumulating evidence highlights the prominent changes within the lung metastatic niche, resulting in stiffening of the extracellular matrix (ECM). The prevailing concept of cancer evolution encompasses the acquisition of beneficial traits as a consequence of genomic instability, yet it remains elusive to what extend altered lung ECM mechanics feed into this. To investigate this, a tunable 3D bioengineered model, capturing the biophysical and biochemical characteristics of the BC metastatic lung niche is developed. Porcine derived lung decellularized ECM (dECM), combined with norbornene and tetrazine modified click-crosslinkable alginate, recapitulates composition and mechanics of healthy soft (3 kPa) and metastatic stiff (13 kPa) lung niches. Label-free optical microscopy further validates the microarchitectural resemblance between resulting matrices and human lung metastasis samples. Encapsulation of MDA-MB-231 and MCF7 cells reveals that stiffer matrices promote BC cluster growth and DNA damage, indicated by yH2AX, independent of BC subtype. Moreover, this platform is compatible with patient derived cells, which remain viable for 14 days. These findings underscore the critical role of tissue mechanics in regulating BC metastasis progression and demonstrate the utility of the herein developed tunable, physiologically relevant platform for patient-based models.